Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New test may prevent some newly diagnosed breast cancer patients from having to undergo chemotherapy

08.01.2008
A new test that can predict whether a patient’s cancer will spread beyond the breast site has been developed by scientists at the UCD Conway Institute, University College Dublin and St Vincent’s University Hospital, Dublin, Ireland. The test for newly diagnosed breast cancer patients may help some women avoid chemotherapy.

Following validation by a number of independent groups worldwide, in studies involving more than 8,000 patients, the American Society of Clinical Oncology has recommended the test as standard for all newly diagnosed breast cancer patients. The test is not currently available in Ireland, but its developers hope that funding will be made available for its implementation in Ireland in the near future.

By measuring the levels of a particular enzyme in the tumour, the new enzyme test can predict whether the patient’s cancer will spread beyond the breast site or not. If the levels of the enzyme – known as uPA – are found to be high, there is a stronger likelihood of the patient developing ‘secondaries’ or metastasis. This means that the patient would require chemotherapy as well as surgery to fight the disease. However, if the levels of uPA are found to be low, a combination of surgery and radiotherapy may be sufficient in order to address the cancer, helping to minimise the expense and the discomfort of the treatment for the patient.

“At the moment most women undergo long and uncomfortable sessions of chemotherapy after their initial breast surgery, but this new enzyme test can help to offer a more tailored solution for patients,” explains Professor Joe Duffy from the UCD Conway Institute, University College Dublin and St Vincent’s University Hospital, Dublin, Ireland, who led the team of scientists and doctors who developed the test. “This new test may help some women newly diagnosed with breast cancer avoid chemotherapy. It leans towards the concept of personalised treatment rather than giving the chemotherapy blunderbuss to all patients, regardless of whether it is suitable for them or not.”

Breast cancer is one of the most common cancers affecting women in Ireland, second only to non-melanoma skin cancer. As the Irish population ages, it is predicted that numbers of new cases of breast cancer will continue to rise and so the development of this test will be a significant breakthrough for many women.

Dominic Martella | alfa
Further information:
http://www.ucd.ie

More articles from Health and Medicine:

nachricht Study tracks inner workings of the brain with new biosensor
16.08.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Foods of the future
15.08.2018 | Georg-August-Universität Göttingen

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Color effects from transparent 3D-printed nanostructures

New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference

Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

LaserForum 2018 deals with 3D production of components

17.08.2018 | Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

 
Latest News

Smallest transistor worldwide switches current with a single atom in solid electrolyte

17.08.2018 | Physics and Astronomy

Robots as Tools and Partners in Rehabilitation

17.08.2018 | Information Technology

Climate Impact Research in Hannover: Small Plants against Large Waves

17.08.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>